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AbstrACt
Introduction Glaucoma is the second leading cause 
of age-related vision loss worldwide; it is an umbrella 
term that is used to describe a set of complex ocular 
disorders with a multifactorial aetiology. Both genetic and 
lifestyle risk factors for glaucoma are well established. 
Thus far, however, systematic reviews on the heritability 
of glaucoma have focused on the heritability of primary 
open-angle glaucoma only. No systematic review 
has comprehensively reviewed or meta-analysed 
the heritability of other types of glaucoma, including 
glaucoma-related endophenotypes. The aim of this study 
will be to identify relevant scientific literature regarding the 
heritability of both glaucoma and related endophenotypes 
and summarise the evidence by performing a systematic 
review and meta-analysis.
Methods and analysis This systematic review will follow 
the Preferred Reporting Items for Systematic review and 
Meta-Analysis Protocols 2015 checklist, which provides 
a standardised approach for carrying out systematic 
reviews. To capture as much literature as possible, a 
comprehensive step-by-step systematic search will 
be undertaken in MEDLINE (PubMed), EMBASE, Web of 
Science and ScienceDirect, and studies published until 
31 December 2017 will be included. Two reviewers will 
independently search the articles for eligibility according 
to predefined selection criteria. A database will be used for 
screening of eligible articles. The quality of the included 
studies will be rated independently by two reviewers, 
using the National Health Institute Quality Assessment tool 
for Observational Cohort and Cross-Sectional Studies. A 
random-effects model will be used for the meta-analysis. 
This systematic review is registered with the International 
Prospective Register of Systematic Reviews with a 
registration number: CRD42017064504.
Ethics and dissemination We will use secondary 
data from peer-reviewed published articles, and hence 
there is no requirement for ethics approval. The results 
of this systematic review will be disseminated through 
publication in a peer-reviewed scientific journal.
IntroduCtIon
The eye is one of the most important sense 
organs, and vision loss may generate various 
degrees of psychological suffering that 
can be greater than the distress resulting 
from other forms of sensory impairment.1 
According to a 2010 WHO estimate, there 
are 285 million people visually impaired, of 
which 39 million are blind.2 The prevalence 
of infection-related blindness is decreasing 
globally; however, age-related blindness is 
increasing throughout the world; this could 
be due to an increasingly aged population or 
technological advancements in screening for 
blindness.3 
Some ocular diseases are more likely to 
occur in old age. Cataract, glaucoma, diabetic 
retinopathy and macular degeneration are 
the most common age-related eye diseases.4–7 
The prevalence of these disorders varies with 
different ethnicities and socioeconomic back-
grounds.6–8 Ocular functions such as visual 
acuity, visual field, and night vision deterio-
rate as these eye disorders progress. But age 
is not the only risk factor; many of these disor-
ders have a genetic component as well.9–12
Among the age-related ocular disorders, 
glaucoma is the leading cause of irrevers-
ible blindness worldwide,13 and disparities 
exist in its classification.14 The International 
Society for Geographical and Epidemiolog-
ical Ophthalmology has developed a robust 
definition of glaucoma for epidemiolog-
ical purposes by including several empirical 
strengths and limitations of this study
 ► The inclusion of endophenotypes, in addition to 
that of the heritability of glaucoma itself, is a novel 
approach of our meta-analysis and systematic 
review providing important information for genetic 
research of glaucoma.
 ► Possible heterogeneity in heritability estimates will 
be explored through conducting subgroup/sensitivity 
analyses.
 ► Heritability estimates derived from different data 
analysis methods may not be directly comparable.
 ► A straightforward interpretation of pooled heritability 
estimates in this meta-analyses may be complicated 
by the variation of heritability estimates between 
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factors, such as optic nerve head findings and visual 
field defects.15 Thus, glaucoma is an umbrella term that 
is used to describe a set of complex ocular disorders 
with multifactorial aetiology.14 15 It can be defined as a 
progressive loss of retinal ganglion cells associated with 
characteristic structural changes to the optic nerve and 
visual function.16 It is asymptomatic until it is severe, thus 
many patients have a delay in diagnosis or are examined 
only after the advanced visual field loss has occurred.14 17 
Glaucoma is classified into primary and secondary cate-
gories. Important risk factors for primary glaucoma are 
intraocular pressure, age and family history; however, the 
biomolecular mechanisms are still poorly defined.18–22 
Secondary glaucoma is a heterogeneous group of diseases 
resulting from other eye diseases, trauma, use of corti-
costeroids or conditions such as pigment dispersion or 
pseudoexfoliation.23 24
Primary glaucoma may be subdivided into primary 
open-angle glaucoma (POAG) and primary angle closure 
glaucoma (PACG). Although POAG is the most common 
type of glaucoma, PACG tends to be more prevalent in 
certain ethnic groups.13 22 In a 2014 systematic review, 
the global prevalence of POAG and PACG combined 
was estimated to be approximately 4% in a population 
aged 40–80 years.13 The prevalence of visual impairment 
due to glaucoma appears to be age-related as well, and 
in a randomly selected sample of 5147 Australians, the 
prevalence was found to be low (~1%) in those aged 60 
years compared with those older than 90 years (4%).4 A 
systematic review of 50 population-based studies reported 
that the prevalence of POAG is relatively high in African 
populations aged ≥40, with an estimated prevalence of 
2%–4%.13 25 Moreover, the prevalence of PACG is found 
to be relatively higher (~1%) in adult Asian popula-
tions.13 22
Studies have demonstrated a strong association 
between the development of POAG and a positive family 
history.10 25–29 In a longitudinal study of 224 siblings of 156 
clinically confirmed POAG cases, there was a significantly 
increasing trend in both prevalence and incidence of the 
disease with age and a lifetime risk estimated of approx-
imately 20% by age 70.27 Other studies also suggested 
that the risk of POAG is higher in siblings of glaucoma 
cases than in their parents or children.26 28 29 In a popula-
tion-based study in Nottingham, UK, the risk of glaucoma 
among siblings of POAG cases was about 10% (with an 
OR of 3.69), which is greater than in parents (~6%; OR 
2.17) and in children (~1%; OR 1.12).27 Studies from the 
Netherlands and India reported similar findings, with a 
higher prevalence of POAG in siblings (~10% to 15%) 
than in parent–offspring family connections (~1% to 
4%), respectively.26 29
Historically, the effect of specific genes in the devel-
opment of glaucoma has been largely unknown. In the 
1960s, Becker et al studied patients with POAG as well as 
their relatives, and proposed that POAG was a genetically 
determined disease, where the recessive homozygous 
‘gg’ genotype represents glaucoma, and the alternative 
homozygous ‘nn’ and the heterozygous ‘ng’ genotypes 
represent non-glaucoma.30
More recently, however, researchers have elucidated 
both causative and associative genes for glaucoma 
risk.20 31–33 Family studies have indicated that glaucoma 
can be inherited as a Mendelian autosomal-dominant 
or recessive trait, but only 3%–5% of adult-onset POAG 
cases are attributed to single-gene or Mendelian forms 
of glaucoma.34 35 The vast majority of cases have a multi-
factorial basis and are caused by the combined effects of 
many genetic and environmental factors.35
The source of phenotypic variation among individuals 
in a population originates from both environmental and 
genetic factors, as well as various interactions between 
them.31 36 Heritability (h2) can be defined as ‘the propor-
tion of variance in a particular trait due to variation in 
genetic factors among individuals in that population’.37–39 
The total variation (variance) in a phenotype (VP) can 
then be broken down into two parts: the genotypic vari-
ance (VG) and the remaining variance (VE), due to the 
environment.38
Within the last 30 years, classical twin studies have been 
conducted to establish the relative importance of genes 
and environment in glaucoma risk. Twin studies are an 
excellent source of information to disentangle and quan-
tify the relative contributions of genes, the shared envi-
ronment and the unique environment with respect to 
complex traits.39 40
Population-based genetic studies continue to confirm 
that many ocular traits have a genetic component.9 These 
traits show substantial variation in human populations 
and many are highly heritable.9 25 30 31 41–44 Glaucoma-re-
lated endophenotypes, sometimes called intermediate 
phenotypes, are powerful tools in the identification of 
genes contributing to glaucoma as they are more likely 
to be directly influenced by the genes than the resulting 
disease itself.45–47 An endophenotype is defined as a 
heritable trait that is associated with a disease and that 
can be objectively measured, but is not a direct symptom 
of the disease.47 48 Traits such as central corneal thick-
ness, optic cup area, optic disc area, vertical cup-to-disc 
ratio and intraocular pressure are some well established 
endophenotypes for glaucoma.45
Heritability estimates for glaucoma endophenotypes 
differ between studies. For example, for intraocular 
pressure, estimates range from h2=0.35, in a total of 
2620 subjects from extended pedigrees from The Neth-
erlands,41 to h2=0.50 in 133 subjects from nuclear family 
groups in the USA.42 Similarly, heritability estimates for 
optic disc parameters range from 0.66 to 0.77 for optic 
cup area, 0.52 to 0.83 for disc area and 0.48 to 0.66 for 
vertical cup-to-disk ratio.9
So far, systematic reviews on the heritability of glaucoma 
have only focused on the heritability of POAG.9 25 Indeed, 
no systematic review has comprehensively reviewed nor 
meta-analysed the heritability of other types of glau-
coma, including PACG and congenital glaucoma, or 
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of genetic risk (ie, heritability) are imperative when 
studying diseases with differing prevalences in different 
ethnicities. It will be an important factor in the near 
future when patients’ genotypes may be used for person-
alised estimates of disease risk, and it is also a prerequisite 
for further gene finding studies. Heritability estimates are 
to be specific to the disease being studied (eg, POAG vs 
PACG), the populations studied (eg, Caucasians vs Asians) 
and the particular circumstances from which they were 
derived.9 43 A systematic review and meta-analysis of the 
genetic contribution to glaucoma and glaucoma-related 
endophenotypes will thus provide important insights and 
assist researchers in designing gene finding studies in the 
future.
The objective of this systematic review will be to identify 
relevant studies regarding the heritability of glaucoma 
and related endophenotypes and summarise the evidence 
through meta-analysis. Heritability estimation, commonly 
reported in per cent, is the outcome measurement that 
we will synthesise and report from several studies.
The current study will address the following research 
questions: (1) How much of the variance in glaucoma 
and glaucoma-related endophenotypes is due to genetic 
factors? (2) What is the proportion of variance accounted 
for by additive genetic influences (A), common environ-
ment (C) and unique environment (E)? (3) Do herita-
bility estimates vary between different populations and 
study designs?
MEthods And AnAlysIs
This systematic review was initiated in March 2017 and 
is registered with the International Prospective Register 
of Systematic Reviews with a registration number 
CRD42017064504, available at http://www. crd. york. 
ac. uk/ PROSPERO/. This systematic review will follow 
the Preferred Reporting Items for Systematic review 
and Meta-Analysis Protocols (PRISMA-P) 2015 check-
list, which consists of a list of 17 items that provide a 
standardised guide for carrying out systematic reviews, 
including construction of a protocol, testing for bias and 
heterogeneity, and other aspects of the review process.49 
Similarly, the quality of the individual studies included 
in the systematic review will be rated independently by 
two reviewers using the National Health Institute Quality 
Assessment tool for Observational Cohort and Cross-Sec-
tional Studies.50
Inclusion criteria
Articles describing heritability results based on (1) family, 
(2) twin, (3) adoption and (4) Genome Wide Associa-
tion study designs or that could be estimated from intra-
class correlations or linear regression coefficients will be 
included. Heritability estimates for any type of glaucoma 
or endophenotypes related to pressure (intraocular pres-
sure), angle (anterior chamber depth, anterior chamber 
volume, angle opening distance, angle recess area, trabec-
ular iris space area or Bruch’s membrane opening), disc 
morphology (cup area, cup diameter, disc area, disc diam-
eter, rim area, vertical or horizontal cup-to-disc ratio), 
ganglion cell complex, retinal nerve fibre layer, or central 
corneal thickness will be considered. The search will be 
restricted to articles describing studies in human subjects 
written in the English language. However, papers written 
in other languages with at least an English abstract will 
also be considered. All heritability studies from peer-re-
viewed journals, published until 31 December 2017, will 
be included.
Exclusion criteria
Papers that did not estimate heritability, did not specify 
ethnicity or estimated explained genetic variance from 
only significant Single-Nucleotide Polymorphisms (SNPs) 
or genetic loci will be excluded.
search strategy
To capture as much literature as possible, an initial 
limited search of MEDLINE (PubMed) will be performed 
using an initial set of search terms. This will be followed 
by the identification of additional search terms from 
the titles and abstracts, and from the Medical Subject 
Heading (MeSH) index terms used to describe the initial 
identified articles (table 1). Second, using all identified 
keywords and index terms, a comprehensive and system-
atic search will be undertaken in MEDLINE, EMBASE, 
Web of Science, and ScienceDirect. In addition, Google 
Scholar will be used as a supplementary search database. 
Third, relevant papers from the reference lists of those 
articles captured in step 2 will be manually searched for 
additional input. References will be exported to RefWorks 
citation management software and duplicates will be 
removed. Full text, as well as relevant data, of all selected 
papers will be retrieved, and authors of the original arti-
cles will be contacted by email if additional information 
is required.
Two reviewers (NGA and AN), will independently eval-
uate the abstracts for eligibility, according to predefined 
selection criteria. A database will be used for screening 
of eligible articles. Any disagreements will be resolved 
through discussion between the two evaluators, but if 
consensus cannot be reached, a third person will be 
consulted. Finally, selected publications will be approved 
by a senior investigator.
Quality control and data extraction
For assessing the quality of individual articles in a system-
atic review, there are a variety of standard tools currently 
in use. However, most of these tools failed to include 
critical assessment elements relevant to heritability and 
genetic studies.51
We found that the National Health Institute Quality 
Assessment tool for Observational Cohort and Cross-Sec-
tional Studies50 is most suitable to assess the quality of 
selected articles in this current study. Quality assessment 
evaluation includes whether the research question/objec-
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randomness of participation and inclusion/exclusion 
criteria are clearly specified and defined; whether quality 
of measurement is ensured in the clinical examination 
of quantitative (endo)phenotypes; if the method of data 
analysis and outcome measure was clearly; defined and if 
confounding variables were controlled for their impact 
on the dependent variable. The heterogeneity of heri-
tability estimation between articles will also be reported 
using Cochrane’s Q test and I2 statistic. These tests assess 
whether there are genuine differences underlying the 
results of the studies, or whether the variation in results 
is through chance alone. The presence of any potential 
publication bias will be visualised with funnel plots, and 
any asymmetry of the funnel plots will be statistically 
tested with an Egger’s test.
The quality of this study will be reported according to 
the PRISMA-P 2015 checklist, which guides the reviewer 
in planning and carrying out systematic reviews49 (online 
supplementary file 1). The full text of the potentially 
eligible articles will be retrieved and stored in an online 
citation manager (RefWorks) for accessibility and data 
synthesis.
The data extraction for eligible articles will be archived 
in a database, and in order to ensure all relevant data 
are collected per study, a standardised form will be used 
(online supplementary file 2). To minimise the risk of 
transcription errors, data extraction will be conducted 
independently by two reviewers. The number of articles 
reviewed, the number of full-text studies retrieved and 
the number of studies excluded will be reported using 
the PRISMA flow chart (online supplementary file 3).
data synthesis and statistical analysis
The endophenotypes will be clustered into groups: pres-
sure, angle, cornea, retinal nerve fibre layer and disc 
morphology. The different types of glaucoma will also 
be clustered into primary and secondary: open-angle 
glaucoma, angle-closure glaucoma or exfoliation, as 
well as congenital glaucoma. Presuming that heritability 
estimates are different between populations, we will 
use a random-effects model for meta-analyses. Separate 
meta-analyses will be performed for each cluster. Pooled 
heritability estimates including 95% confidence inter-
vals, and summary statistics for quantitative data will be 
described and presented in tables and figures. Quanti-
tative assessment of heterogeneity in findings between 
studies and publication bias will be performed and 
reported. Heritability estimates from different study 
designs and statistical methods, as well as the possible 
factors that might explain the variation in heritability, will 
be discussed in detail.
subgroup analysis
For assessing the possible factors that might explain 
the variation in heritability, we will use a number of 
approaches. The factors we will explore include ethnicity, 
study design, data analysis method, number of variables 
controlled for confounding, mean age and methodolog-
ical quality score. Ethnicity will be classified according 




#1 “Quantitative Trait, Heritable” [MeSH] OR “Endophenotypes”[MeSH] OR Heritab*[tiab] 36 287
#2 Glaucoma[MeSH] OR Glaucoma*[tiab] 62 936
#3 Normal tension glaucoma[MeSH] OR Low tension glaucoma[MeSH] OR Exfoliation Glaucoma[MeSH] 
OR pseudoexfoliation glaucoma[MeSH] OR Exfoliation Syndrome[MeSH] OR Pigment dispersion 
syndrome[MeSH] OR Pigment dispersion syndrome[tiab] OR pds[tiab] OR Congenital glaucoma [MeSH] 
OR Buphthalmos[tiab] OR Buphthalmus[tiab] OR “Juvenile glaucoma”[tiab]
19 552
#4 “Intraocular pressure”[tiab] OR ‘“Ocular pressure”[tiab] OR iop[tiab] OR “Ocular hypertension”[tiab] 
OR “ocular biometric”[tiab] OR “Central corneal thickness”[tiab] OR “Corneal shape”[tiab] OR “Axial 
length”[tiab] OR Linear cup-disc ratio OR lcdr OR “Vertical cup to disc ratio”[tiab] OR Vertical cup-to-
disc ratio[tiab] OR vcdr[tiab] OR vertical cup:disc ratio[tiab] OR vertical cup-disc ratio[tiab] OR “Corneal 
hysteresis”[tiab] OR “Anterior chamber depth”[tiab] OR “Anterior chamber angle” OR “Narrow anterior 
chamber” OR “Optic disc diameter”[tiab] OR “Cup area”[tiab] OR “Disc area”[tiab] OR “Rim area”[tiab] 
OR “Retinal nerve fibre layer”[tiab] OR “Cilioretinal arteries”[tiab] OR “Retinal ganglion cell layer” OR 
Horizontal cup:disc ratio[tiab] OR “Disc diameter”[tiab] OR “Cup disc ratio”[tiab] OR “Ganglion cell 
complex thickness”[tiab] OR “Shallow anterior chamber”[tiab] OR “Iris thickness”[tiab] OR “Iris area”[tiab] 
OR “Plateau iris” OR “Pupil diameter”[tiab] OR “Pupil size”[tiab] OR “Iridotrabecular angle width”[tiab] 
OR “Bruch’s membrane opening” OR “Neuroretinal rim” OR Excavation[tiab] OR Cupping[tiab] OR “Inner 
plexiform layer thickness”[tiab] OR “angle opening” distance”[tiab] OR aod[tiab] OR “trabecular iris space 
area” OR tisa[tiab] OR “angle recess area”[tiab] OR ara [tiab]
62 213
#5 #2 OR #3 OR #4 106 800
#6 #1 AND #5 194
*Preliminary search conducted on 14 December 2017 at 07:20:51.
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to reference 52, which meta-analysed the global prevalence 
of POAG in different ethnicities. Additionally, for intra-
ocular pressure, h2 estimates will be subgrouped based 
on the device reported in the literature. The potential 
effect of mean age, sex, ethnicity, study design, data anal-
ysis method and the number of variables controlled for 
confounding will also be statistically tested with meta-re-
gression analyses.
sensitivity analysis
Possible sources of heterogeneity will be determined 
with the Baujat plot.53 Following the discovery of outliers, 
sensitivity analysis will be carried out by excluding the 
three most heterogeneous articles per cluster. To explore 
the sensitivity of h2 estimates to mean age and ethnicity, 
analyses will be conducted on a series of combinations of 
these variables.
Ethical consideration and result dissemination
This systematic review will use secondary data from 
peer-reviewed published articles, hence there is no 
requirement for ethics approval. The results of this 
systematic review will be disseminated through publica-
tion in a relevant, peer-reviewed journal and presented at 
pertinent conferences.
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